Brunswick company making scientific advances toward more effective prescriptions at lower costs

BRUNSWICK, Maine — The side effects of any new pharmaceutical drug can often be scarier than what they’re meant to treat; but how can drug companies do better testing?

They can start with a company called InSphero. Armand Wolf, the Chief Scientific Officer for the company, spent years working in drug development in the pharmaceutical field.

“Most of the drugs, when they’re just reaching clinical phase, 90% of them are failing,” says Wolf. Those drugs are failing – on average – 10 years into testing. “It will cost about $1-2 Billion, so this is a huge waste of money.” Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025